Literature DB >> 21216816

Cardiac dysfunction in juvenile dermatomyositis: a case-control study.

Thomas Schwartz1, Helga Sanner, Trygve Husebye, Berit Flatø, Ivar Sjaastad.   

Abstract

OBJECTIVE: To compare cardiac function in patients with juvenile dermatomyositis (JDM) with matched controls, and examine associations between pathological electrocardiography (ECG), echocardiographic abnormalities and disease variables in patients with JDM.
METHODS: A total of 59 patients with JDM, examined a median 16.8 years (range 2-38 years) after disease onset, were compared with 59 age-matched and sex-matched controls. Echocardiography, including early diastolic transmitral flow/early diastolic tissue velocity (E/E') as a marker for diastolic dysfunction, and 12-channel ECG were performed and analysed blinded to patient information. Disease activity and damage were assessed by clinical examination at follow-up and chart review.
RESULTS: E/E' was elevated (>9.5) in 13 (22%) patients versus 0 controls (p<0.001). In all, 10 patients presented with pathological ECG compared to 4 controls (p=0.054). Previous or current hypertension was found in 12 patients versus 0 controls (p<0.001). Among the patients, pathological ECG was found in 6/13 patients with versus 4/44 without elevated E/E' (p=0.002); and systolic blood pressure was correspondingly 132±24 mm Hg versus 112±18 mm Hg in the groups (p=0.012). E/E' correlated with cumulative organ damage assessed at follow-up (r(sp) 0.41, p=0.001) and disease activity at 1 year (r(sp) 0.56, p<0.001), which also predicted pathological E/E' after controlling for age and gender. During disease course, 12% of patients with JDM developed pericarditis.
CONCLUSION: Only patients with JDM and no controls had subclinical left ventricular diastolic dysfunction; the patients with elevated E/E' also had high prevalence of pathological ECG and hypertension. High disease activity 1-year post diagnosis predicted high E/E' at follow-up. The findings suggest that subclinical heart disease is related to the systemic nature of JDM.

Entities:  

Mesh:

Year:  2011        PMID: 21216816     DOI: 10.1136/ard.2010.137968

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

2.  Juvenile dermatomyositis: new insights and new treatment strategies.

Authors:  Neil Martin; Charles K Li; Lucy R Wedderburn
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-02       Impact factor: 5.346

3.  Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.

Authors:  Micah J Eimer; Wendy J Brickman; Roopa Seshadri; Rosalind Ramsey-Goldman; David D McPherson; Beverly Smulevitz; Neil J Stone; Lauren M Pachman
Journal:  J Pediatr       Date:  2011-07-23       Impact factor: 4.406

Review 4.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 5.  Treatment of Juvenile Dermatomyositis: An Update.

Authors:  Charalampia Papadopoulou; Lucy R Wedderburn
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

6.  Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity.

Authors:  Min Wang; Hehuang Xie; Sheela Shrestha; Simone Sredni; Gabrielle A Morgan; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2012-10

7.  Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies.

Authors:  Yingxian Liu; Ligang Fang; Wei Chen; Yanlin Zhu; Xue Lin; Yining Wang; Xiao Li; Qian Wang; Zhenyu Liu
Journal:  Cardiovasc Diagn Ther       Date:  2020-06

8.  213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015.

Authors:  Olivier Benveniste; Lisa G Rider
Journal:  Neuromuscul Disord       Date:  2016-05-27       Impact factor: 4.296

9.  Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study.

Authors:  Birgit Nomeland Witczak; Thomas Schwartz; Zoltan Barth; Eli Taraldsrud; May Brit Lund; Trond Mogens Aaløkken; Berit Flatø; Ivar Sjaastad; Helga Sanner
Journal:  Rheumatol Int       Date:  2022-01-04       Impact factor: 3.580

10.  Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage.

Authors:  Helga Sanner; Thomas Schwartz; Berit Flatø; Maria Vistnes; Geir Christensen; Ivar Sjaastad
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.